Hepatopulmonary syndrome: A pulmonary vascular complication of liver disease

Clinics in Chest Medicine

Volumn 17, Issue 1, 1996, Pages 35-48

  Castro, M ^a   Krowka, M J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALMITRINE DIMESILATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOPHOSPHAMIDE; INDOMETACIN; METHYLENE BLUE; PREDNISONE; PROSTAGLANDIN F2 ALPHA; SOMATOSTATIN DERIVATIVE; TAMOXIFEN; VASODILATOR AGENT;

ARTERIAL GAS; CLINICAL EXAMINATION; CONTRAST ECHOCARDIOGRAPHY; GARLIC; HUMAN; HYPOXEMIA; INTERVENTIONAL RADIOLOGY; LIVER DISEASE; LIVER TRANSPLANTATION; LUNG BLOOD VESSEL; LUNG COMPLICATION; LUNG HEMODYNAMICS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW;

EID: 0029876370     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70297-5     Document Type: Article

References (82)

1. G. Abrams C. Jaffe P. Hoffer Hepatopulmonary syndrome: A comparison of contrast echocardiogram and lung perfusion scan Hepatology 20 1994 105A
2. A.G.N. Agusti J. Roca J. Bosch Effects of propranolol on arterial oxygenation and oxygen transport to tissues in patients with cirrhosis Am Rev Respir Dis 142 1990 306 310
3. A.G. Agusti J. Roca R. Rodriguez-Roisin Pulmonary hemodynamics and gas exchange during exercise in liver cirrhosis Am Rev Respir Dis 139 1989 485 491
4. H. Allgaier M. Jeserich M. Haag Severe hepatopulmonary syndrome: First successful treatment by TIPS. Gastroenterology 106 1994 A857
5. P. Andrivet J. Cadranel B. Housset Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency—effects of indomethacin Chest 103 1993 500 507
6. P. Berthelot J.G. Walker S. Sherlock Arterial changes in the lungs in cirrhosis of the liver—lung spider nevi N Engl J Med 274 1966 291 298
7. J.L. Cadranel B.J. Milleron J.-F. Cadranel Severe hypoxemia-associated intrapumonary shunt in a patient with chronic liver disease: Improvement after medical treatment Am Rev Respir Dis 146 1992 526 527
8. S.H. Caldwell L.J. Jeffers O.S. Narula Ancient remedies revisited: Does Allium sativum (garlic) palliate the hepatopulmonary syndrome? J Clin Gastroenterol 15 1992 248 250
9. C. Caramelo S. Fernandez-Gallardo J.C. Santos Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver Eur J Clin Invest 17 1987 7 11
10. Y. Castaing G. Manier Hemodynamic disturbances and VA/Q matching in hypoxemic cirrhotic patients Chest 96 1989 1064 1069
11. M. Castro M.J. Krowka K.C. Beck Survival in liver transplant patients with pulmonary hypertension—correlation with pulmonary function. Am J Respir Crit Care Med 149 1994 A734
12. Castro M. Krowka M.J. Schroeder D.R. Predictors of pulmonary hypertension and survival in liver transplant patients Mayo Clin Proc 1996 in press
13. S.W. Chang N. Ohara Pulmonary circulatory dysfunction in rats with biliary cirrhosis. An animal model of the hepatopulmonary syndrome Am Rev Respir Dis 145 1992 798 805
14. G.S. Crary B.A. Burke B.A. Alford Pulmonary arteriovenous shunting in a child with cirrhosis of the liver Am J Dis Child 143 1989 749 751
15. F.S. Daoud J.T. Reeves J.W. Schaefer Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis J Clin Invest 51 1972 1076 1080
16. H.H. Davis D.J. Schwartz S.S. Lefrak Alveolarcapillary oxygen disequilibrium in hepatic cirrhosis Chest 73 1978 507 511
17. R.J. Dimand M.B. Heyman J.E. Lavine Hepatopulmonary syndrome: Response to hepatic transplantation Hepatology 14 1991 55A
18. E.S. Edell D.A. Cortese M.J. Krowka Severe hypoxemia and liver disease Am Rev Respir Dis 140 1989 1631 1635
19. B.S. Edwards E.K. Weir W.D. Edwards Coexistent pulmonary and portal hypertension: Morphologic and clinical features J Am Coll Cardiol 10 1987 1233 1238
20. M. EI Gamal J.B. Stoker E.M. Spiers Cyanosis complicating hepatic cirrhosis: Report of a case due to multiple pulmonary arteriovenous fistulas Am J Cardiol 25 1970 490 494
21. L.S. Eriksson C. Soderman B.G. Ericzon Normalization of ventilation/perfusion relationships after liver transplantation in patients with decompensated cirrhosis: Evidence for a hepatopulmonary syndrome Hepatology 12 1990 1350 1357
22. R.W. Felt B.E. Kozak J. Rosch Hepatogenic pulmonary angiodysplasia treated with coil-spring embolization Chest 91 1987 920 922
23. M. Flückiger Vorkommen von trommelschlagel-formigen Fingerendphalangen ohne chronische Veranderungeng an den Lungen oder am Herzen Wien Med Wochenschr 34 1884 1457
24. M.G. Genovesi D.F. Tierney G.V. Taplin An intravenous radionuclide method to evaluate hypoxemia caused by abnormal alveolar vessels Am Rev Respir Dis 114 1976 59 65
25. 2 J Appl Physiol 49 1980 107 112
26. P. Gines W. Jimenez V. Arroyo Atrial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic circulation Hepatology 8 1988 636 642
27. R.J. Groszmann Hyperdynamic state in chronic liver diseases. J Hepatol 17 1993 S38 S40
28. G. Hedenstierna C. Soderman L.S. Eriksson Ventilation-perfusion inequality in patients with non-alcoholic liver cirrhosis Eur Respir J 4 1991 711 717
29. R.C. Hewes Cerebral embolism—first manifestation of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasias Cardiovasc Intervent Radiol 8 1985 151 155
30. W.E. Hopkins A.D. Waggoner B. Barzilai Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease Am J Cardiol 70 1992 516 519
31. D. Jensen S. Pothamsetty D. Ganger Clinical manifestations of cirrhotic patients with intrapulmonary shunts. Gastroenterology 106 1994 A912
32. T.C. Kennedy R.J. Knudson Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis Chest 72 1977 305 309
33. A. Keys A.M. Snell Respiratory properties of the arterial blood in normal man and in patients with disease of the liver: Position of the oxygen dissociation curve J Clin Invest 17 1938 59
34. H.J. Kowalski W.H. Abelman The cardiac output at rest in Laennec's cirrhosis J Clin Invest 32 1953 1025 1033
35. R.E. Kravath E.M. Scarpelli J. Bernstein Hepatogenic cyanosis: Arteriovenous shunts in chronic active hepatitis J Pediatr 78 1971 238 245
36. M.J. Krowka Clinical management of hepatopulmonary syndrome [review] Semin Liver Dis 13 1993 414 422
37. M.J. Krowka D.A. Cortese Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations [review] Chest 105 1994 1528 1537
38. M.J. Krowka D.A. Cortese Hepatopulmonary syndrome: An evolving perspective in the era of liver transplantation [comment] [review] Hepatology 11 1990 138 142
39. M.J. Krowka D.A. Cortese Severe hypoxemia associated with liver disease: Mayo Clinic experience and experimental use of almitrine bismesylate Mayo Clin Proc 62 1987 164 173
40. M.J. Krowka E.R. Dickson D.A. Cortese Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue Chest 104 1993 515 521
41. M.J. Krowka A.J. Tajik E.R. Dickson Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates—screening by two-dimensional contrast-enhanced echocardiography Chest 97 1990 1165 1170
42. J.-M. Laberge M. Brandt P. Lebecque Reversal of cirrhosis-related pulmonary shunting in two children by orthotopic liver transplantation Transplantation 53 1992 1135 1138
43. W. MacNee T. Buist N. Finlayson Multiple microscopic pulmonary arteriovenous connections in the lungs presenting as cyanosis Thorax 40 1985 316 318
44. G. Maggiore C. Borgna-Pignati E. Marni Pulmonary arteriovenous fistulas: An unusual complication of congenital hepatic fibrosis J Pediatr Gastroenterol Nutr 2 1983 183 186
45. J. Marco J. Diego M.L. Villaneuva Elevated plasma glucagon levels in cirrhosis of the liver N Engl J Med 289 1973 1107 1111
46. V. Mayoral T. Higgenbottam G. Cremona Exhaled nitric oxide (NO) is elevated in patients with hepatopulmonary syndrome. Am Rev Respir Dis 149 1994 A26
47. K.A. McAllister K.M. Grogg D.W. Johnson Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type I Nat Genet 8 1994 345 351
48. J. McCloskey C. Schleien K. Schwarz Severe hypoxemia and intrapulmonary shunting resulting from cirrhosis reversed by liver transplantation in a pediatric patient J Pediat 118 1991 902 904
49. I.F. McMurtry K.G. Morris Platelet-activating factor—cause of pulmonary vasodilation in the rat Am Rev Respir Dis 134 1986 757 762
50. C. Melot R. Naeije P. Dechamps Pulmonary and extrapulmonary contributors to hypoxemia in liver cirrhosis Am Rev Respir Dis 139 1989 632 640
51. J.H. Moyer G. Glantz A.N. Brest Pulmonary arteriovenous fistulae: Physiologic and clinical considerations Am J Med 32 1962 417
52. F. Murad Cyclic guanosine monophosphate as a mediator of vasodilation J Clin Invest 78 1986 1 5
53. J.F. Murray A.M. Dawson S. Sherlock Circulatory changes in chronic liver disease Am J Med 24 1958 358 367
54. R. Naeije R. Hallemans P. Mols Hypoxic pulmonary vasoconstriction in liver cirrhosis Chest 80 1981 570 574
55. S.O. Parks L.B. Beerman J.C. Gartner Echocardiographic findings before and after liver transplantatin Am J Cardiol 55 1985 1373 1378
56. M.A. Perrella E.S. Edell M.J. Krowka Endothelium-derived relaxing factor in pulmonary and renal circulations during hypoxia. Am J Physiol 263 1992 R45 50
57. J.J. Poterucha M.J. Krowka E.R. Dickson Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy Hepatology 21 1995 96 100
58. E.D. Robin D. Laman B.R. Horn Platypnea related to orthodeoxia caused by true vascular lung shunts N Engl J Med 294 1976 941 943
59. R. Rodriguez-Roisin M. Krowka Is severe arterial hypoxaemia due to hepatic disease an indication for liver transplantation? A new therapeutic approach [editorial] Eur Respir J 7 1994 839 842
60. R. Rodriguez-Roisin A.G. Agusti J. Roca The hepatopulmonary syndrome: New name, old complexities [editorial] Thorax 47 1992 897 902
61. R. Rodriguez-Roisin J. Roca A. Agusti Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis Am Rev Respir Dis 135 1987 1085 1092
62. G. Rolla C. Bucca L. Brussino Methylene blue in the hepatopulmonary syndrome [letter] N Engl J Med 331 1994 1098
63. R. Rydell F.W. Hoffbauer Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis Am J Med 21 1956 450 460
64. A. Sakai N.F. Voelkel Cyclic adenosine monophosphate inhibits pulmonary vasoconstriction Lung 166 1988 221 231
65. O. Salem V. Dindzans V. Freeman Liver transplantation following preoperative closure of intrapulmonary shunts [abstract] Hepatology 10 1989 569
66. S. Schwartz D. Pound Hepatopulmonary syndrome: Failure of response to somatostatin analogue [abstract]. Gastroenterology 102 1992 A882
67. S. Schwarzenberg D. Freese W. Regelmann Resolution of severe intrapulmonary shunting after liver transplantation Chest 103 1993 1271 1273
68. V. Scott A. Miro Y. Kang Reversibility of the hepatopulmonary syndrome by orthotopic liver transplantation Transplant Proc 25 1993 1787 1788
69. H. Shijo H. Sasaki K. Nishimaru Recurrent intracranial hemorrhagic episodes in hepatopulmonary syndrome Int Med 31 1992 786 790
70. H. Shijo H. Sasaki H. Sakata Reversibility of hepatopulmonary syndrome evidenced by serial pulmonary perfusion scan Gastro Japonica 28 1993 126 131
71. H. Shijo H. Sasaki K. Yuh Effects of indomethacin on hepatogenic pulmonary angiodysplasia Chest 99 1991 1027 1029
72. C. Soderman A. Juhlindannfelt L. Lagerstrand Ventilation-perfusion relationships and central haemodynamics in patients with cirrhosis-effects of a somatostatin analogue J Hepatol 21 1994 52 57
73. J. Stoller D. Moodie W. Schiavone Reduction of intrapulmonary shunt and resolution of digital clubbing associated with primary biliary cirrhosis after liver transplantation Hepatology 11 1990 54 58
74. P.B. Terry R.I.J. White K.H. Barth Pulmonary arteriovenous malformations: Physiologic observations and results of therapeutic balloon embolization N Engl J Med 308 1983 1197 1200
75. P. Vallance S. Moncada Hyperdynamic circulation in cirrhosis: A role for nitric oxide? Lancet 337 1991 776 778
76. L. Van Obbergh M. Carlier S. Clement de Clety Liver transplantation and pulmonary gas exchanges in hypoxemic children Am Rev Respir Dis 148 1993 1408 1410
77. D.H. VanThiel R.R. Schade J.B. Gavaler Medical aspects of liver transplantation. Hepatology 4 suppl 1984 79S 83S
78. B.J.R. Whittle S. Moncada Nitric oxide: The elusive mediator of the hyperdynamic circulation in cirrhosis? Hepatology 16 1992 1089 1092
79. A. Williams P. Trewby R. Williams Structural alterations to the pulmonary circulation in fulminant hepatic failure Thorax 34 1979 447 453
80. J.D. Wolfe D.P. Tashkin F.E. Holly Hypoxemia of cirrhosis: Detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method Am J Med 63 1977 746 754
81. J. Yanagisawa H. Kurihara S. Kimura A novel potent vasoconstrictor peptide (endothelin) produced by vascular endothelial cells Nature 332 1988 411 415
82. R.D. Zipser J.C. Hoefs P.F. Speckart Prostaglandins: Modulator of renal function and pressor resistance in chronic liver disease J Clin Endocrinol Metab 48 1979 895 900